/
Aibotics, Inc. promotes the study of psychedelics for the treatment of mental health issues and supports the creation of both natural and synthetic molecules for the development of appropriate treatments. Aibotics also intends to deploy technology from its parent company, Ehave, Inc., in the collection of research and clinical data to further the study of the effects of psyche…
The business is unprofitable at the operating level (-84501.74% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Negative free cash flow of -$458K. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$2K
Net Income (TTM)
-$2M
▼ -19.9% YoY
Op. Margin
-84501.74%
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
-$458K
▼ -76.9% YoY
Op. Cash Flow (TTM)
-$458K
▼ -76.9% YoY
Net Debt
$1M
Cash & Equiv.
$256K
Continue Research